Duodenal-Type Follicular Lymphoma: Understanding Your Pathology Report

Section Editor: David Driman MBChB FRCPC
November 17, 2026


Print this article

Duodenal-type follicular lymphoma is a slow-growing cancer and a type of non-Hodgkin lymphoma that starts in the lining of the small intestine. It develops from B cells, a type of immune cell, and most often forms small white bumps in the duodenum, the first part of the small intestine. It is usually found by chance during an upper endoscopy. Most people have no symptoms, the disease rarely spreads beyond the intestine, and the outlook is excellent.

Duodenal-type follicular lymphoma behaves very differently from the more common form of follicular lymphoma that starts in the lymph nodes. This article explains how duodenal-type follicular lymphoma is diagnosed, what your pathology report tests show, and why many people are watched rather than treated.

Who gets duodenal-type follicular lymphoma?

Duodenal-type follicular lymphoma is found mostly in middle-aged and older adults. Recent studies report a median age at diagnosis in the late 50s to early 60s, with a range from the 30s to the 80s. Men and women are affected about equally. It is diagnosed more often in parts of Asia, where upper endoscopy is widely used for screening and small, symptom-free lesions are more likely to be found.

What causes duodenal-type follicular lymphoma?

The cause of duodenal-type follicular lymphoma is not known. Like other follicular lymphomas, it usually carries a genetic change called a translocation between chromosomes 14 and 18, written as t(14;18). This change switches on a gene called BCL2, which helps cells survive longer than they should. This extra survival allows abnormal B cells to accumulate slowly over time.

Studies of the tissue around duodenal-type follicular lymphoma show signs of long-term inflammation. Researchers think this local environment may help explain why the lymphoma tends to stay in the intestine and grow so slowly.

What are the symptoms of duodenal-type follicular lymphoma?

Most people with duodenal-type follicular lymphoma have no symptoms. The lymphoma is usually found during an upper endoscopy done for another reason, such as heartburn, indigestion, anemia, or cancer screening. When symptoms occur, they are usually mild, such as abdominal discomfort or slow bowel bleeding.

How is the diagnosis made?

A pathologist diagnoses duodenal-type follicular lymphoma by examining a biopsy of the duodenum under a microscope. Doctors take the biopsy during an upper endoscopy, a procedure in which a thin, flexible camera is passed through the mouth and stomach into the duodenum. The lymphoma most often appears as many small whitish bumps or granules, usually in the second part of the duodenum.

Under the microscope, the pathologist sees rounded clusters of lymphocytes called neoplastic follicles. These follicles sit in the mucosa, the inner lining of the duodenum, and sometimes extend into the submucosa below it. The cells look like the cells normally found in germinal centers, the part of a lymph node where B cells mature. Most cells are small, with a few large cells present.

Once the diagnosis is confirmed, doctors do more tests to see whether the lymphoma is anywhere else in the body. These usually include a CT scan or a PET scan, and often a capsule endoscopy or balloon enteroscopy to look at the rest of the small intestine. A colonoscopy and a bone marrow biopsy may also be done. The pathologist uses special stains to confirm the diagnosis, as described in the next section.

Immunohistochemistry

Pathologists use immunohistochemistry to confirm duodenal-type follicular lymphoma and to separate it from other lymphomas of the small intestine. This test uses antibodies to show which proteins the lymphoma cells make. Your report may list the following results.

  • CD20. CD20 is a protein found on B cells. A positive result shows that the lymphoma is made of B cells.
  • CD10 and BCL6. CD10 and BCL6 are proteins made by germinal center B cells. Positive results show the lymphoma comes from this type of B cell.
  • BCL2. Normal germinal center cells do not make BCL2. A positive result inside the follicles supports a diagnosis of follicular lymphoma rather than a reactive, noncancerous follicle.
  • CD21 and CD23. These proteins highlight follicular dendritic cells, support cells that form a mesh inside normal follicles. In duodenal-type follicular lymphoma, this mesh is usually thin and pushed to the edge of each follicle. This pattern helps separate it from classic follicular lymphoma involving the bowel.
  • CD3, CD5, and cyclin D1. These results are negative in duodenal-type follicular lymphoma. A negative cyclin D1 result helps rule out mantle cell lymphoma, which can also form many small bumps in the bowel.
  • Ki-67. Ki-67 shows the percentage of cells that are dividing. In duodenal-type follicular lymphoma, this number is usually low, which fits with a slow-growing lymphoma.

Some laboratories also test for the t(14;18) translocation using fluorescence in situ hybridization (FISH). A positive result shows that the BCL2 gene has moved next to an immune gene, supporting the diagnosis. Not every case needs every test.

How is duodenal-type follicular lymphoma different from classic follicular lymphoma?

Duodenal-type follicular lymphoma and classic follicular lymphoma look similar under the microscope and share the t(14;18) translocation. However, they behave very differently. For this reason, the WHO Classification of Hematolymphoid Tumors (5th edition, 2022) and the International Consensus Classification (2022) both list duodenal-type follicular lymphoma as its own subtype.

  • Classic follicular lymphoma usually starts in lymph nodes and often spreads widely by the time it is found. Duodenal-type follicular lymphoma is usually limited to the small intestine.
  • How it behaves. Duodenal-type follicular lymphoma grows very slowly and rarely spreads to lymph nodes or other organs. In some cases, it shrinks or disappears without treatment.
  • How it looks with special stains. The follicular dendritic cell pattern shown by CD21 differs between the two, as described above.

Classic follicular lymphoma can also involve the duodenum. When this happens, the duodenal biopsy can look like duodenal-type follicular lymphoma. The imaging tests done after the biopsy help tell the two apart, because classic follicular lymphoma usually involves lymph nodes as well.

Histologic grade

Follicular lymphoma has traditionally been graded by counting the large cells, called centroblasts, under the microscope. In duodenal-type follicular lymphoma, almost all cases are low grade, described as grade 1 or grade 1 to 2. This means the lymphoma is made mostly of small cells, which fits with its slow growth.

The WHO classification (5th edition, 2022) no longer requires a grade for follicular lymphoma, while the International Consensus Classification (2022) still does. Your report may therefore give a grade or may not. A low grade helps predict slow behavior and supports decisions such as watchful waiting. If the pathologist sees sheets of large cells, the report will describe this, because it can mean the lymphoma has changed into a faster-growing type.

Staging

Duodenal-type follicular lymphoma is staged using the Lugano staging system for gastrointestinal lymphoma (1994). This system is based on imaging and endoscopy rather than on the biopsy alone. It describes whether the lymphoma is limited to the bowel or has spread to lymph nodes or other organs.

  • Stage I. The lymphoma is limited to the digestive tract. This includes a single area or several separate areas, such as the duodenum and the jejunum. Most people with duodenal-type follicular lymphoma have stage I disease.
  • Stage II1. The lymphoma has spread to lymph nodes next to the bowel.
  • Stage IIB. The lymphoma has spread to lymph nodes farther away in the abdomen.
  • Stage IIE. The lymphoma has grown through the outer wall of the bowel into a nearby organ or tissue.
  • Stage IV. The lymphoma has spread widely to other organs or to lymph nodes above the diaphragm.

Lymphoma found in other parts of the small intestine does not raise the stage, because it is still within the digestive tract. Many people with duodenal-type follicular lymphoma also have small lesions in the jejunum or ileum.

What is the prognosis?

The prognosis for duodenal-type follicular lymphoma is excellent. In a Japanese study of 26 patients, 100 in 100 were alive five years after diagnosis. About 86 in 100 showed no signs of growth during that time, and about 14 in 100 did. In a Brazilian study of 53 patients, only 3 had disease that progressed, and no patient died of the lymphoma during follow-up.

Some cases shrink or disappear without any treatment. Change into a faster-growing lymphoma, such as diffuse large B-cell lymphoma, is rare but has been reported. The following features are linked to the outcome.

  • Stage. Disease limited to the bowel (stage I) has the best outlook. Spread to lymph nodes or other organs raises the chance that treatment will be needed.
  • Grade. Low-grade disease, made mostly of small cells, is expected. Large numbers of large cells suggest a change to a faster-growing type.
  • Type of lesion. Larger nodules or masses, rather than small granules, have been linked to a more advanced stage.

What happens after the diagnosis?

After duodenal-type follicular lymphoma is confirmed, the next steps depend on the stage, the grade in the pathology report, and whether the lymphoma causes symptoms. A hematologist or oncologist usually leads care, working with a gastroenterologist. The care team may consider the following options.

  • Watchful waiting. For most people with stage I disease and no symptoms, no treatment is started. Instead, the lymphoma is followed with regular endoscopy and imaging. This is the most common approach. In one study, people who were watched did as well as people treated right away with rituximab and chemotherapy.
  • Rituximab. Rituximab is an antibody drug that attaches to CD20 on the lymphoma cells. It may be considered when the lymphoma causes symptoms, grows, or involves a larger area.
  • Radiation therapy. Radiation to the affected area is used in a small number of people with disease limited to one region.
  • Rituximab with chemotherapy. This is usually reserved for disease that has spread widely or changed into a faster-growing lymphoma.

Because the lymphoma can grow slowly over many years, long-term follow-up is important even for people who never need treatment. Your care team can tell you how often you will have endoscopy and scans.

Questions to ask your doctor

  • Where in my small intestine was the lymphoma found, and how many areas were involved?
  • Was the lymphoma low grade, and did the pathologist see any large cells?
  • Did the CD21 stain show the duodenal-type pattern?
  • Was a t(14;18) test done, and what did it show?
  • Could this be classic follicular lymphoma involving the duodenum instead?
  • What imaging tests will I need to find out my stage?
  • Will the rest of my small intestine be examined with a capsule or balloon endoscopy?
  • Do I need a bone marrow biopsy?
  • What is my stage under the Lugano system?
  • Is watchful waiting a reasonable option for me?
  • What signs or symptoms would lead you to start treatment?
  • How often will I need endoscopy and scans?

Related articles on MyPathologyReport.com

A+ A A-
Was this article helpful?